BioCentury
ARTICLE | Clinical News

Thyrogen thyrotropin alpha regulatory update

December 5, 2011 8:00 AM UTC

Sanofi's Genzyme Corp. subsidiary notified FDA that it has resumed intermittent global shipments of thyroid cancer treatment Thyrogen thyrotropin alfa but that supply will continue to be restricted u...